Evidence mapPaperPMID 38628646Full record

ArticleFrontiers in pharmacology2024

Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study.

Abdulaziz Alsalem, Mohammed M Alsultan, Faisal Alqarni, Abdullah Almangour, Lolwa Alsharekh, Saleem Alenazi, Saleh Alzahrani, Raghad A Almanqour, Abdullah Alazmi, Abdullah Alzahrani

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abdulaziz AlsalemDepartment of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.
Mohammed M AlsultanDepartment of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Faisal AlqarniDepartment of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.
Abdullah AlmangourDepartment of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.
Lolwa AlsharekhDepartment of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.
Saleem AlenaziDepartment of Cardiology, Security Forces Hospital, Riyadh, Saudi Arabia.
Saleh AlzahraniDepartment of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.
Raghad A AlmanqourDepartment of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.
Abdullah AlazmiCollege of Medicine Al-Jouf University, Sakaka, Saudi Arabia.
Abdullah AlzahraniDepartment of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiovascular diseasedapagliflozindiureticsheart failureSGLT2 inhibitors

Identifiers

PMID38628646
PMCPMC11018970

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.